Sign inGet started

Levine Mark S.

Insider CIK 1617236 · FLXN SVP & General Counsel · NERV Vice President,General Counsel · IMVT Chief Legal Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IMVT Immunovant, Inc. S Sale2024-11-202024-11-223,650$25.45 $92.9K319,228SEC↗
IMVT Immunovant, Inc. S Sale2024-10-232024-10-254,361$29.53 $128.8K322,878SEC↗
IMVT Immunovant, Inc. S Sale2024-10-162024-10-182,860$28.79 $82.3K327,239SEC↗
IMVT Immunovant, Inc. S Sale2024-08-212024-08-233,164$31.84 $100.7K330,230SEC↗
IMVT Immunovant, Inc. S Sale2024-08-212024-08-23131$32.32 $4.2K330,099SEC↗
IMVT Immunovant, Inc. S Sale2024-07-242024-07-264,015$27.76 $111.5K333,394SEC↗
IMVT Immunovant, Inc. S Sale2024-07-172024-07-19147$30.55 $4.5K337,409SEC↗
IMVT Immunovant, Inc. S Sale2024-07-172024-07-192,358$29.64 $69.9K337,556SEC↗
IMVT Immunovant, Inc. S Sale2024-05-222024-05-243,242$29.65 $96.1K339,914SEC↗
IMVT Immunovant, Inc. S Sale2024-04-242024-04-263,963$28.90 $114.5K343,156SEC↗
IMVT Immunovant, Inc. S Sale2024-04-172024-04-192,225$29.94 $66.6K347,119SEC↗
IMVT Immunovant, Inc. S Sale2024-04-172024-04-197,602$28.80 $218.9K349,344SEC↗
IMVT Immunovant, Inc. A Award deriv2024-04-022024-04-0468,723— $068,723SEC↗
IMVT Immunovant, Inc. A Award2024-04-022024-04-0454,978— $0356,946SEC↗
IMVT Immunovant, Inc. S Sale2024-02-222024-02-232,134$36.15 $77.1K301,968SEC↗
IMVT Immunovant, Inc. S Sale2024-01-262024-01-292,981$37.91 $113.0K304,148SEC↗
IMVT Immunovant, Inc. S Sale2024-01-262024-01-2946$38.45 $1.8K304,102SEC↗
IMVT Immunovant, Inc. S Sale2023-11-222023-11-24124$33.52 $4.2K307,129SEC↗
IMVT Immunovant, Inc. S Sale2023-11-222023-11-243,128$32.75 $102.4K307,253SEC↗
IMVT Immunovant, Inc. S Sale2023-10-252023-10-274,107$34.66 $142.3K310,381SEC↗
IMVT Immunovant, Inc. S Sale2023-08-242023-08-2512,285$20.30 $249.4K314,489SEC↗
IMVT Immunovant, Inc. S Sale2023-08-242023-08-251$20.89 $21314,488SEC↗
IMVT Immunovant, Inc. S Sale2023-07-262023-07-273,917$21.63 $84.7K326,774SEC↗
IMVT Immunovant, Inc. S Sale2023-04-252023-04-262,633$16.29 $42.9K330,691SEC↗
IMVT Immunovant, Inc. A Award deriv2023-04-122023-04-14113,821— $0113,821SEC↗
IMVT Immunovant, Inc. A Award2023-04-122023-04-1487,664— $0333,324SEC↗
IMVT Immunovant, Inc. S Sale2023-01-262023-01-2710,156$18.51 $188.0K245,660SEC↗
IMVT Immunovant, Inc. A Award deriv2022-08-172022-08-19169,648— $0169,648SEC↗
IMVT Immunovant, Inc. A Award2022-08-172022-08-19112,816— $0255,816SEC↗
IMVT Immunovant, Inc. A Award deriv2022-01-282022-01-31383,000— $0383,000SEC↗
IMVT Immunovant, Inc. A Award2022-01-282022-01-31143,000— $0143,000SEC↗
FLXN Flexion Therapeutics Inc D To issuer deriv2021-11-192021-11-1918,000— $00SEC↗
FLXN Flexion Therapeutics Inc D To issuer deriv2021-11-192021-11-1915,500— $00SEC↗
FLXN Flexion Therapeutics Inc D To issuer deriv2021-11-192021-11-1920,000— $00SEC↗
FLXN Flexion Therapeutics Inc D To issuer deriv2021-11-192021-11-1933,333— $00SEC↗
FLXN Flexion Therapeutics Inc D To issuer deriv2021-11-192021-11-19125,000— $00SEC↗
FLXN Flexion Therapeutics Inc D To issuer2021-11-192021-11-19133,486$8.50 $1.13M0SEC↗
FLXN Flexion Therapeutics Inc S Sale2021-07-192021-07-203,945$6.45 $25.4K133,486SEC↗
FLXN Flexion Therapeutics Inc A Award deriv2021-03-012021-03-0320,000— $020,000SEC↗
FLXN Flexion Therapeutics Inc A Award2021-03-012021-03-0330,000— $0137,431SEC↗
FLXN Flexion Therapeutics Inc S Sale2021-01-052021-01-076,829$11.13 $76.0K107,431SEC↗
FLXN Flexion Therapeutics Inc A Award2020-07-162020-07-2038,750— $0114,260SEC↗
FLXN Flexion Therapeutics Inc A Award2020-06-222020-06-241,023$10.83 $11.1K75,510SEC↗
FLXN Flexion Therapeutics Inc A Award deriv2020-03-022020-03-0315,500— $015,500SEC↗
FLXN Flexion Therapeutics Inc A Award2020-03-022020-03-0331,000— $074,487SEC↗
FLXN Flexion Therapeutics Inc S Sale2020-01-032020-01-073,724— $043,487SEC↗
FLXN Flexion Therapeutics Inc A Award2019-06-212019-06-241,213$9.81 $11.9K46,273SEC↗
FLXN Flexion Therapeutics Inc A Award deriv2019-03-012019-03-0518,000— $018,000SEC↗
FLXN Flexion Therapeutics Inc A Award2019-03-012019-03-0536,000— $045,060SEC↗
FLXN Flexion Therapeutics Inc S Sale2019-01-032019-01-04734$12.36 $9.1K9,060SEC↗
FLXN Flexion Therapeutics Inc J Other2018-06-202018-06-22539$21.22 $11.4K8,872SEC↗
FLXN Flexion Therapeutics Inc A Award deriv2018-02-012018-02-0233,333— $033,333SEC↗
FLXN Flexion Therapeutics Inc A Award2018-02-012018-02-028,333— $08,333SEC↗
FLXN Flexion Therapeutics Inc A Award deriv2017-06-262017-06-26125,000— $0125,000SEC↗
NERV Minerva Neurosciences, Inc M Exercise deriv2017-06-012017-06-0517,500— $039,774SEC↗
NERV Minerva Neurosciences, Inc M Exercise2017-06-012017-06-0517,500$5.19 $90.8K17,500SEC↗
NERV Minerva Neurosciences, Inc S Sale2017-06-012017-06-0517,500$11.00 $192.5K0SEC↗
NERV Minerva Neurosciences, Inc M Exercise deriv2017-01-042017-01-06250— $057,274SEC↗
NERV Minerva Neurosciences, Inc M Exercise deriv2017-01-042017-01-0617,250— $051,750SEC↗
NERV Minerva Neurosciences, Inc S Sale2017-01-042017-01-0617,500$12.00 $210.0K0SEC↗
NERV Minerva Neurosciences, Inc M Exercise2017-01-042017-01-06250$5.19 $1.3K17,500SEC↗
NERV Minerva Neurosciences, Inc M Exercise2017-01-042017-01-0617,250$4.71 $81.2K17,250SEC↗
NERV Minerva Neurosciences, Inc A Award deriv2016-12-142016-12-1620,000— $020,000SEC↗
NERV Minerva Neurosciences, Inc A Award deriv2016-12-142016-12-1635,000— $035,000SEC↗
NERV Minerva Neurosciences, Inc A Award deriv2015-12-042015-12-0869,000— $069,000SEC↗
NERV Minerva Neurosciences, Inc A Award deriv2015-04-142015-04-1657,524— $057,524SEC↗
NERV Minerva Neurosciences, Inc A Award deriv2014-09-022014-09-0393,541— $093,541SEC↗